Analysed ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) News Sources
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
15-04-2026
yahoo.com
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
19-03-2026
yahoo.com
Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immune Checkpoint Inhibitors
17-03-2026
yahoo.com
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer
27-02-2026
marketbeat.com
Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
24-02-2026
yahoo.com
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress
23-02-2026
yahoo.com
Acrivon Therapeutics Strengthens its Precision Medicine Therapeutics Capabilities with Launch of Internal CLIA-Certified Laboratory
18-02-2026
yahoo.com
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress
23-01-2026
yahoo.com
What is the current price of ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)?
The current price of ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) is $1.67.
ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) absolute price change since previous trading day?
The absolute price change of ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) since the previous trading day is $0.03.
ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) percentage price change since previous trading day?
The percentage price change of ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) since the previous trading day is 1.8293%.
What is the most recent average sentiment score for ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)?
The most recent average sentiment score for ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)?
The most recent sentiment for ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) is .
SEC-8K** Filing Available For ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.